Benzinga

Benzinga

Benzinga

jueves, septiembre 10

Jade Biosciences Inc

JBIONASDAQ
Trade with Public
Trade with Public
$19.06
-0.39-2.01%
al cierre: Sep 8, 5:00 PM EST
$19.20
-0.25-1.29%
Premercado: 5:30 AM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Jade Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Jade Biosciences (JBIO).

Price Target Range — 6 Quarters

Analyst Consensus — 6 Analysts

6Buy
Consensus RatingBuy# Analysts6Avg. Consensus PT$47Upside to Avg. PT+143.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 11, 2026WedbushLaura ChicoPT RaiseOutperform$45→$47
Aug 10, 2026BTIGJulian HarrisonPT RaiseBuy$74→$77
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $47

Wedbush analyst Laura Chico maintains Jade Biosciences (NASDAQ:JBIO) with a Outperform and raises the price target from $45 to $47.
Benzinga Newsdesk

PRO
UBS Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $45

UBS analyst Michael Yee initiates coverage on Jade Biosciences (NASDAQ:JBIO) with a Buy rating and announces Price Target of $45.
Benzinga Newsdesk

PRO
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $45

Wedbush analyst Laura Chico maintains Jade Biosciences (NASDAQ:JBIO) with a Outperform and raises the price target from $34 to $45.
Benzinga Newsdesk

Why Is Jade Biosciences Stock Trading Lower On Monday?

Jade Biosciences reports Phase 1 JADE101 data showing sustained IgA reductions in IgAN, while analyst addresses ADA concerns and timeline expectations.
Vandana Singh

PRO
BTIG Maintains Buy on Jade Biosciences, Raises Price Target to $74

BTIG analyst Julian Harrison maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the price target from $39 to $74.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Jade Biosciences, Raises Price Target to $55

HC Wainwright & Co. analyst Arthur He maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the price target from $45 to $55.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved